Cancer is the second-leading cause of death in the United States, according to a 2026 Cancer Research Institute report.

Researchers at DZNE and Charité—Universitätsmedizin Berlin are working on a targeted therapy for neurological autoimmune ...

A single infusion of an off-the-shelf lentiviral vector generates CAR T cells inside patients with refractory neurologic autoimmune disease. But do the results go beyond existing therapies?

Cancer is the second leading cause of death in the United States, according to a 2026 Cancer Research Institute report. Cancer biologists are keenly aware of this statistic, as it drives them to ...

I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...

If these drugs are designed to target cancer, why don't they work?Treatments that harness the power of the immune system to ...

UCLA researchers developed ready-made cancer-fighting T cells from cord blood stem cells that can attack solid tumors through ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During their preparation for this battle, B cells transiently revert to a more ...

Nephrotic syndrome is caused when the filtering system in the kidneys is damaged, allowing large amounts of protein to leak into the urine. It is ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, which ...